Influence of Custom Orthosis Post Carpometacarpal (CMC) Arthroplasty

NCT ID: NCT05307510

Last Updated: 2024-10-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-21

Study Completion Date

2023-10-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare post-surgical outcomes of individuals who receive either a custom orthosis or prefabricated splint after carpometacarpal arthroplasty.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research study will randomly assign subjects post CMC arthroplasty to Intervention A (prefabricated splint) or Intervention B (custom orthosis). The orthosis and splint being used in this study are both considered standard practice. Subjects will be provided the splint or orthosis at the first post-operative appointment. Subjects who are assigned to Intervention A will be provided a pre-fabricated splint by a member of the surgical team. Subjects who are assigned to Invention B will be evaluated by an occupational therapist and a custom orthosis will be fabricated. Outcome measures include: QuickDASH, Pain Visual Analogue Scale, active range of motion measurements, the Applied Dexterity portion of the Arthritis Hand Function Test except for the putty cutting task, edema, Sandy Grading Score and the Orthotics and Prosthetics User's Survey (OPUS) Satisfaction with Device and Services. Data will be collected at the first, second, and third post-operative appointment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thumb Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention A - prefabricated splint

A prefabricated splint is provided to the client

Group Type ACTIVE_COMPARATOR

Prefabricated splint

Intervention Type DEVICE

Subjects will be provided either a prefabricated splint

Intervention B - custom orthosis

a custom orthosis (wrist splint with thumb spica) is fabricated by an occupational therapist

Group Type EXPERIMENTAL

Custom Orthosis

Intervention Type DEVICE

Subjects will be evaluated by an occupational therapist who will fabricate a custom orthosis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prefabricated splint

Subjects will be provided either a prefabricated splint

Intervention Type DEVICE

Custom Orthosis

Subjects will be evaluated by an occupational therapist who will fabricate a custom orthosis.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* status post CMC arthroplasty
* 18 or older
* able to read and understand English
* capable of independently consenting to health care procedures.

Exclusion Criteria

* if the surgeon identifies risk factors that would preclude random assignment to the control or experimental group
* if subject requests a prefabricated or custom orthosis.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toledo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laura Schmelzer, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Toledo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Toledo Medical Center

Toledo, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UToledo301275

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CMC I Stability Intraoperative
NCT03687775 COMPLETED